243 related articles for article (PubMed ID: 35151889)
1. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT.
Fukuhara H; Yamamoto S; Lai HW; Karashima T; Kurabayashi A; Furihata M; Inoue K
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102757. PubMed ID: 35151889
[TBL] [Abstract][Full Text] [Related]
2. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259
[TBL] [Abstract][Full Text] [Related]
3. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): Cost impact of transurethral resection of bladder tumor in Japan.
Fukuhara H; Hagiwara Y; Oba K; Inoue K
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103758. PubMed ID: 37604217
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.
Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H
Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832
[TBL] [Abstract][Full Text] [Related]
5. 'Real-life experience': recurrence rate at 3 years with Hexvix
Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P
World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385
[TBL] [Abstract][Full Text] [Related]
6. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
[TBL] [Abstract][Full Text] [Related]
8. [Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)].
Sugino Y; Nishikawa K; Kato M; Sasaki T; Kato M; Masui S; Yoshio Y; Kanda H; Sugimura Y; Inoue T
Hinyokika Kiyo; 2021 Jul; 67(7):303-308. PubMed ID: 34353010
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K
Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327
[TBL] [Abstract][Full Text] [Related]
10. Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
Nakagawa R; Nohara T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103574. PubMed ID: 37080348
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.
Miyake M; Nishimura N; Nakai Y; Fujii T; Owari T; Hori S; Morizawa Y; Gotoh D; Anai S; Torimoto K; Tanaka N; Hirao Y; Fujimoto K
Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525423
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder Cancer.
Heer R; Lewis R; Vadiveloo T; Yu G; Mariappan P; Cresswell J; McGrath J; Nabi G; Mostafid H; Lazarowicz H; Kelly J; Duncan A; Penegar S; Breckons M; Wilson L; Clark E; Feber A; Orozco-Leal G; Tandogdu Z; Taylor E; N'Dow J; Norrie J; Ramsay C; Rice S; Vale L; MacLennan G; Hall E
NEJM Evid; 2022 Oct; 1(10):EVIDoa2200092. PubMed ID: 38319866
[TBL] [Abstract][Full Text] [Related]
13. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
[TBL] [Abstract][Full Text] [Related]
14. Investigation on the Usefulness of Photodynamic Diagnosis-assisted Targeted Bladder Biopsy: Japanese Real-world Study.
Arai T; Sazuka T; Oka R; Tsukamoto R; Sato H; Goto Y; Imamura Y; Sakamoto S; Ichikawa T
Anticancer Res; 2023 Aug; 43(8):3615-3621. PubMed ID: 37500129
[TBL] [Abstract][Full Text] [Related]
15. Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.
Watanabe K; Tamura K; Matsushita Y; Watanabe H; Motoyama D; Ito T; Sugiyama T; Otsuka A; Miyake H
Cancer Diagn Progn; 2021; 1(3):201-205. PubMed ID: 35399308
[TBL] [Abstract][Full Text] [Related]
16. Variations in photodynamic diagnosis for bladder cancer due to the quality of endoscopic equipment.
Nohara T; Kamijima T; Fukuda R; Kano H; Shimada T; Nakano T; Kato Y; Kadomoto S; Iwamoto H; Yaegashi H; Iijima M; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102628. PubMed ID: 34808397
[TBL] [Abstract][Full Text] [Related]
17. Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety.
Yamamoto S; Fukuhara H; Karashima T; Inoue K
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101999. PubMed ID: 32920180
[TBL] [Abstract][Full Text] [Related]
18. Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non-muscle-invasive bladder cancer: A comparative study from experienced institutes.
Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
BJUI Compass; 2023 May; 4(3):305-313. PubMed ID: 37025476
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial.
Yu G; Rice S; Heer R; Lewis R; Vadiveloo T; Mariappan P; Penegar S; Clark E; Tandogdu Z; Hall E; Vale L
Eur Urol Open Sci; 2023 Jul; 53():67-77. PubMed ID: 37441343
[TBL] [Abstract][Full Text] [Related]
20. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
